N
IBB icon

Nuveen’s iShares Biotechnology ETF IBB Stock Holding History

Nuveen’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-87,000
Closed -$9.55M – 1054
2018
Q2 		$9.55M Buy
87,000
+12,853
+17% +$1.37M 0.06% 399
2018
Q1 		$7.91M Sell
74,147
-24,197
-25% -$2.68M 0.05% 412
2017
Q4 		$10.5M Buy
+98,344
New +$10.5M 0.07% 381
2017
Q2 		– Sell
-30,000
Closed -$2.93M – 1189
2017
Q1 		$2.93M Buy
+30,000
New +$2.87M 0.02% 601
2016
Q4 		– Sell
-61,875
Closed -$5.97M – 1555
2016
Q3 		$5.97M Buy
+61,875
New +$5.89M 0.03% 499

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nuveen's IBB Position: Q3 2018 in Review

Nuveen sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 87,000 shares — an estimated $9.55M sold.

Nuveen first reported a position in IBB in Q3 2016 and held it in 5 quarters. The position peaked at $10.5M in Q4 2017. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

  • Nuveen reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
  • Nuveen sold 87,000 iShares Biotechnology ETF shares in Q3 2018, an estimated $9.55M.
  • Nuveen first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 5 quarters.
  • Nuveen's iShares Biotechnology ETF position peaked at $10.5M in Q4 2017.
  • 631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Nuveen's 13F filing for Q3 2018, filed 13 Nov 2018.